Cysteine protease cathepsins in atherosclerosis and abdominal aortic aneurysm

Clinical Reviews in Bone and Mineral Metabolism

Volumn 9, Issue 2, 2011, Pages 138-147

  Sjöberg, Sara ^a   Shi, Guo Ping ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Abdominal aortic aneurysm; Atherosclerosis; Cathepsin; Cathepsin inhibitor; Protease inhibitor

Indexed keywords

CATHEPSIN; CATHEPSIN B; CATHEPSIN F; CATHEPSIN K; CATHEPSIN K INHIBITOR; CATHEPSIN L; CATHEPSIN S; CATHEPSIN S INHIBITOR; CYSTEINE PROTEINASE; DIPEPTIDYL PEPTIDASE I; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ODANACATIB;

ABDOMINAL AORTA ANEURYSM; ANTIGEN PRESENTATION; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CELL MIGRATION; DRUG TARGETING; FOAM CELL; HUMAN; LEUKOCYTE; LIPID METABOLISM; MACROPHAGE; PATHOGENESIS; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SMOOTH MUSCLE FIBER;

EID: 79960073695     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-011-9098-2     Document Type: Review

References (82)

1. P Libby RT Lee 2000 Matrix matters Circulation 102 16 1874 1876 11034930 1:STN:280:DC%2BD3cvovVegsw%3D%3D
2. L Robert AM Robert B Jacotot 1998 Elastin-elastase-atherosclerosis revisited Atherosclerosis 140 2 281 295 9862271 10.1016/S0021-9150(98)00171-3 1:CAS:528:DyaK1cXms1SrsLg%3D (Pubitemid 28535319)
3. VY Reddy QY Zhang SJ Weiss 1995 Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages Proc Natl Acad Sci USA 92 9 3849 3853 7731994 10.1073/pnas.92.9.3849 1:CAS:528:DyaK2MXlsVSlu7k%3D
4. GK Sukhova GP Shi DI Simon HA Chapman P Libby 1998 Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells J Clin Invest 102 3 576 583 9691094 10.1172/JCI181 1:CAS:528:DyaK1cXlt1eguro%3D (Pubitemid 28376160)
5. W Kafienah D Bromme DJ Buttle LJ Croucher AP Hollander 1998 Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix Biochem J 331 Pt 3 727 732 9560298 1:CAS:528:DyaK1cXjt12iu7s%3D (Pubitemid 28211893)
6. GP Shi JS Munger JP Meara DH Rich HA Chapman 1992 Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease J Biol Chem 267 11 7258 7262 1373132 1:CAS:528:DyaK3sXhvVKkur4%3D
7. S Kitamoto GK Sukhova J Sun M Yang P Libby V Love, et al. 2007 Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice Circulation 115 15 2065 2075 17404153 10.1161/CIRCULATIONAHA.107.688523 1:CAS:528:DC%2BD2sXjvFKjtbY%3D (Pubitemid 46625958)
8. M Yang Y Zhang J Pan J Sun J Liu P Libby, et al. 2007 Cathepsin L activity controls adipogenesis and glucose tolerance Nat Cell Biol 9 8 970 977 17643114 10.1038/ncb1623 1:CAS:528:DC%2BD2sXosVSltbw%3D
9. B Wang J Sun S Kitamoto M Yang A Grubb HA Chapman, et al. 2006 Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors J Biol Chem 281 9 6020 6029 16365041 10.1074/jbc.M509134200 1:CAS:528: DC%2BD28XhvVeju7Y%3D (Pubitemid 43847703)
10. G Dubin 2005 Proteinaceous cysteine protease inhibitors Cell Mol Life Sci 62 6 653 669 15770418 10.1007/s00018-004-4445-9 1:CAS:528:DC%2BD2MXktlymt74%3D
11. A Hall I Ekiel RW Mason F Kasprzykowski A Grubb M Abrahamson 1998 Structural basis for different inhibitory specificities of human cystatins C and D Biochemistry 37 12 4071 4079 9521728 10.1021/bi971197j 1:CAS:528: DyaK1cXhsVOltb8%3D (Pubitemid 28166428)
12. GK Hansson P Libby 2006 The immune response in atherosclerosis: a double-edged sword Nat Rev Immunol 6 7 508 519 16778830 10.1038/nri1882 1:CAS:528:DC%2BD28XmtFegsLc%3D (Pubitemid 43980523)
13. M Gustafsson J Boren 2004 Mechanism of lipoprotein retention by the extracellular matrix Curr Opin Lipidol 15 5 505 514 15361785 10.1097/00041433-200410000-00003 1:CAS:528:DC%2BD2cXnsV2kurY%3D (Pubitemid 39336577)
14. GK Sukhova Y Zhang JH Pan Y Wada T Yamamoto M Naito, et al. 2003 Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice J Clin Invest 111 6 897 906 12639996 1:CAS:528:DC%2BD3sXitlOjtrk%3D (Pubitemid 37074965)
15. S Jormsjo DM Wuttge A Sirsjo C Whatling A Hamsten S Stemme, et al. 2002 Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice Am J Pathol 161 3 939 945 12213722 10.1016/S0002-9440(10)64254-X (Pubitemid 34988381)
16. ZS Galis GK Sukhova MW Lark P Libby 1994 Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest 94 6 2493 2503 7989608 10.1172/JCI117619 1:CAS:528:DyaK2MXisFWgsrg%3D (Pubitemid 24379627)
17. ZS Galis JJ Khatri 2002 Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 3 251 262 11861412 1:CAS:528:DC%2BD38Xhs1Wrsb4%3D (Pubitemid 34633925)
18. J Liu GK Sukhova JS Sun WH Xu P Libby GP Shi 2004 Lysosomal cysteine proteases in atherosclerosis Arterioscler Thromb Vasc Biol 24 8 1359 1366 15178558 10.1161/01.ATV.0000134530.27208.41 1:CAS:528:DC%2BD2cXmtValtbk%3D (Pubitemid 39056073)
19. K Oorni M Sneck D Bromme MO Pentikainen KA Lindstedt M Mayranpaa, et al. 2004 Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro J Biol Chem 279 33 34776 34784 15184381 10.1074/jbc.M310814200 (Pubitemid 39318110)
20. Y Bando E Kominami N Katunuma 1986 Purification and tissue distribution of rat cathepsin L J Biochem 100 1 35 42 3759937 1:CAS:528:DyaL28XltFSrurg%3D
21. LJ Joseph LC Chang D Stamenkovich VP Sukhatme 1988 Complete nucleotide, deduced amino acid sequences of human, murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts J Clin Invest 81 5 1621 1629 2835398 10.1172/JCI113497 1:CAS:528:DyaL1MXhvFSl
22. J Liu GK Sukhova JT Yang J Sun L Ma A Ren, et al. 2006 Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells Atherosclerosis 184 2 302 311 15982660 10.1016/j. atherosclerosis.2005.05.012 1:CAS:528:DC%2BD28XhsFCksg%3D%3D (Pubitemid 43049714)
23. SP Lutgens KB Cleutjens MJ Daemen S Heeneman 2007 Cathepsin cysteine proteases in cardiovascular disease FASEB J 21 12 3029 3041 17522380 10.1096/fj.06-7924com 1:CAS:528:DC%2BD2sXhtFKntbrE
24. E Lutgens SP Lutgens BC Faber S Heeneman MM Gijbels MP de Winther, et al. 2006 Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation Circulation 113 1 98 107 16365196 10.1161/CIRCULATIONAHA.105.561449 1:CAS:528:DC%2BD2MXhtlCrtbnF (Pubitemid 43958494)
25. M Papaspyridonos A Smith KG Burnand P Taylor S Padayachee KE Suckling, et al. 2006 Novel candidate genes in unstable areas of human atherosclerotic plaques Arterioscler Thromb Vasc Biol 26 8 1837 1844 16741146 10.1161/01.ATV.0000229695.68416.76 1:CAS:528:DC%2BD28XmvFaksbs%3D (Pubitemid 44305338)
26. Y Yasuda Z Li D Greenbaum M Bogyo E Weber D Bromme 2004 Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages J Biol Chem 279 35 36761 36770 15192101 10.1074/jbc.M403986200 1:CAS:528: DC%2BD2cXmvFCmsb4%3D (Pubitemid 39129024)
27. J Chen CH Tung U Mahmood V Ntziachristos R Gyurko MC Fishman, et al. 2002 In vivo imaging of proteolytic activity in atherosclerosis Circulation 105 23 2766 2771 12057992 10.1161/01.CIR.0000017860.20619.23 (Pubitemid 34615149)
28. KJ Rodgers DJ Watkins AL Miller PY Chan S Karanam WH Brissette, et al. 2006 Destabilizing role of cathepsin S in murine atherosclerotic plaques Arterioscler Thromb Vasc Biol 26 4 851 856 16410454 10.1161/01.ATV.0000203526. 75772.4b 1:CAS:528:DC%2BD28XitlKmtro%3D (Pubitemid 43732162)
29. AO Samokhin A Wong P Saftig D Bromme 2008 Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice Atherosclerosis 200 1 58 68 18291403 10.1016/j.atherosclerosis.2007.12.047 1:CAS:528:DC%2BD1cXhtVensbzN
30. CL Jackson 2007 Defining and defending murine models of plaque rupture Arterioscler Thromb Vasc Biol 27 4 973 977 17377151 10.1161/01.ATV.0000261545. 53586.f0 1:CAS:528:DC%2BD2sXksVKjsLk%3D (Pubitemid 46606734)
31. J Guo I Bot R de Nooijer SJ Hoffman GB Stroup EA Biessen, et al. 2009 Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice Cardiovasc Res 81 2 278 285 19015136 10.1093/cvr/cvn311 1:CAS:528:DC%2BD1MXntVOhsQ%3D%3D
32. R de Nooijer I Bot JH von der Thusen MA Leeuwenburgh HS Overkleeft AO Kraaijeveld, et al. 2009 Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis Arterioscler Thromb Vasc Biol 29 2 188 194 19095996 10.1161/ATVBAHA.108.181578
33. AO Samokhin PA Lythgo JY Gauthier MD Percival D Bromme 2010 Pharmacological inhibition of cathepsin S decreases atherosclerotic lesions in Apoe-/- mice J Cardiovasc Pharmacol 56 1 98 105 20410833 10.1097/FJC. 0b013e3181e23e10 1:CAS:528:DC%2BC3cXovFSltL8%3D
34. S Anidjar PB Dobrin M Eichorst GP Graham G Chejfec 1992 Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms J Vasc Surg 16 2 139 147 1386635 10.1067/mva.1992.35585 1:STN:280: DyaK38zls1CgtA%3D%3D
35. K Shimizu RN Mitchell P Libby 2006 Inflammation and cellular immune responses in abdominal aortic aneurysms Arterioscler Thromb Vasc Biol 26 5 987 994 16497993 10.1161/01.ATV.0000214999.12921.4f 1:CAS:528:DC%2BD28XjsVers7g%3D (Pubitemid 43732102)
36. RW Thompson S Liao JA Curci 1997 Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms Coron Artery Dis 8 10 623 631 9457444 10.1097/00019501-199710000-00005 1:STN:280:DyaK1c7hvVOksg%3D%3D (Pubitemid 28029588)
37. EL Henderson YJ Geng GK Sukhova AD Whittemore J Knox P Libby 1999 Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms Circulation 99 1 96 104 9884385 1:CAS:528:DyaK1MXnsFCkug%3D%3D (Pubitemid 29035963)
38. J Sun GK Sukhova M Yang PJ Wolters LA MacFarlane P Libby, et al. 2007 Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice J Clin Invest 117 11 3359 3368 17932568 10.1172/JCI31311 1:CAS:528:DC%2BD2sXht12isrnJ (Pubitemid 350096992)
39. PB Dobrin WH Baker WC Gley 1984 Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms Arch Surg 119 4 405 409 6322726 1:STN:280:DyaL2c7ltlaqtg%3D%3D (Pubitemid 14166703)
40. JC Isenburg DT Simionescu BC Starcher NR Vyavahare 2007 Elastin stabilization for treatment of abdominal aortic aneurysms Circulation 115 13 1729 1737 17372168 10.1161/CIRCULATIONAHA.106.672873 1:CAS:528: DC%2BD2sXjsVCju7Y%3D (Pubitemid 46648609)
41. GP Shi GK Sukhova A Grubb A Ducharme LH Rhode RT Lee, et al. 1999 Cystatin C deficiency in human atherosclerosis and aortic aneurysms J Clin Invest 104 9 1191 1197 10545518 10.1172/JCI7709 1:CAS:528:DyaK1MXntVOgsr0%3D (Pubitemid 29536290)
42. H Abdul-Hussien RG Soekhoe E Weber JH von der Thusen R Kleemann A Mulder, et al. 2007 Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases Am J Pathol 170 3 809 817 17322367 10.2353/ajpath.2007.060522 1:CAS:528:DC%2BD2sXjs1Wls70%3D (Pubitemid 47339351)
43. T Aoki H Kataoka R Ishibashi K Nozaki N Hashimoto 2008 Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms Stroke 39 9 2603 2610 18635848 10.1161/STROKEAHA.107.513648 1:CAS:528:DC%2BD1cXpvFGntLY%3D
44. AM Adkison SZ Raptis DG Kelley CT Pham 2002 Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis J Clin Invest 109 3 363 371 11827996 1:CAS:528:DC%2BD38XhtV2isLc%3D (Pubitemid 34141810)
45. SJ Van Vickle-Chavez WS Tung TS Absi TL Ennis D Mao JP Cobb, et al. 2006 Temporal changes in mouse aortic wall gene expression during the development of elastase-induced abdominal aortic aneurysms J Vasc Surg 43 5 1010 1020 16678698 10.1016/j.jvs.2006.01.004
46. MB Pagano MA Bartoli TL Ennis D Mao PM Simmons RW Thompson, et al. 2007 Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms Proc Natl Acad Sci USA 104 8 2855 2860 17301245 10.1073/pnas.0606091104 1:CAS:528:DC%2BD2sXisVSnt7g%3D (Pubitemid 46327969)
47. L Bai L Beckers E Wijnands SP Lutgens MV Herias P Saftig, et al. 2010 Cathepsin K gene disruption does not affect murine aneurysm formation Atherosclerosis 209 1 96 103 19775691 10.1016/j.atherosclerosis.2009.09.001 1:CAS:528:DC%2BC3cXis1ensLY%3D
48. S Schulte J Sun P Libby L Macfarlane C Sun M Lopez-Ilasaca, et al. 2010 Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice Am J Pathol 177 1 456 463 20472891 10.2353/ajpath.2010.090381 1:CAS:528:DC%2BC3cXpslCrsLc%3D
49. M Naghavi R John S Naguib MS Siadaty R Grasu KC Kurian, et al. 2002 pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque Atherosclerosis 164 1 27 35 12119190 10.1016/S0021-9150(02)00018-7 1:CAS:528:DC%2BD38Xlt12ltrw%3D (Pubitemid 34765634)
50. KS Moulton 2006 Angiogenesis in atherosclerosis: gathering evidence beyond speculation Curr Opin Lipidol 17 5 548 555 16960504 10.1097/01.mol. 0000245261.71129.f0 1:CAS:528:DC%2BD28XptF2rtLY%3D (Pubitemid 44372686)
51. AC van der Wal AE Becker 1999 Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability Cardiovasc Res 41 2 334 344 10341833 10.1016/S0008-6363(98)00276-4 (Pubitemid 29087330)
52. AC Newby 2005 Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev 85 1 1 31 15618476 10.1152/physrev.00048.2003 1:CAS:528:DC%2BD2MXotFalsw%3D%3D (Pubitemid 40171256)
53. JA Madri D Graesser 2000 Cell migration in the immune system: the evolving inter-related roles of adhesion molecules and proteinases Dev Immunol 7 2-4 103 116 11097205 10.1155/2000/79045 1:CAS:528:DC%2BD3cXos1yns7s%3D
54. E Bengtsson J Nilsson S Jovinge 2008 Cystatin C and cathepsins in cardiovascular disease Front Biosci 13 5780 5786 18508621 10.2741/3115 1:CAS:528:DC%2BD1cXnsVOisrg%3D
55. GK Sukhova B Wang P Libby JH Pan Y Zhang A Grubb, et al. 2005 Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice Circ Res 96 3 368 375 15653570 10.1161/01.RES. 0000155964.34150.F7 1:CAS:528:DC%2BD2MXhtF2nsLk%3D (Pubitemid 40279912)
56. SO Olofsson J Boren 2005 Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis J Intern Med 258 5 395 410 16238675 10.1111/j.1365-2796.2005.01556.x 1:CAS:528:DC%2BD2MXht1CgsrrL (Pubitemid 41546555)
57. M Linke RE Gordon M Brillard F Lecaille G Lalmanach D Bromme 2006 Degradation of apolipoprotein B-100 by lysosomal cysteine cathepsins Biol Chem 387 9 1295 1303 16972799 10.1515/BC.2006.160 1:CAS:528:DC%2BD28XhtVOhtr7K (Pubitemid 44402077)
58. SP Lutgens N Kisters E Lutgens RI van Haaften CT Evelo MP de Winther, et al. 2006 Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic J Pathol 210 3 334 343 16972305 10.1002/path.2054 1:CAS:528:DC%2BD28Xht1GktbvF (Pubitemid 44660512)
59. A Boullier DA Bird MK Chang EA Dennis P Friedman K Gillotre-Taylor, et al. 2001 Scavenger receptors, oxidized LDL, and atherosclerosis Ann N Y Acad Sci 947 214 222 11795269 10.1111/j.1749-6632.2001.tb03943.x 1:CAS:528: DC%2BD38Xns1yisw%3D%3D Discussion 22-3
60. L Lindstedt M Lee K Oorni D Bromme PT Kovanen 2003 Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells Biochem Biophys Res Commun 312 4 1019 1024 14651973 10.1016/j.bbrc.2003.11.020 1:CAS:528:DC%2BD3sXpsVSjs74%3D (Pubitemid 37490917)
61. W Li XM Yuan AG Olsson UT Brunk 1998 Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation Arterioscler Thromb Vasc Biol 18 2 177 184 9484981 10.1161/01.ATV.18.2.177 1:CAS:528:DyaK1cXhtlOkt7c%3D (Pubitemid 28277593)
62. W Li XM Yuan 2004 Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis Ann N Y Acad Sci 1030 427 433 15659826 10.1196/annals.1329.053 1:CAS:528:DC%2BD2MXivFKrsLg%3D (Pubitemid 40378942)
63. P Duewell H Kono KJ Rayner CM Sirois G Vladimer FG Bauernfeind, et al. 2010 NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 7293 1357 1361 20428172 10.1038/nature08938 1:CAS:528:DC%2BC3cXltl2mu7w%3D
64. I Tabas 2005 Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency Arterioscler Thromb Vasc Biol 25 11 2255 2264 16141399 10.1161/01.ATV.0000184783.04864.9f 1:CAS:528:DC%2BD2MXhtFCisbfM (Pubitemid 41552640)
65. W Li H Dalen JW Eaton XM Yuan 2001 Apoptotic death of inflammatory cells in human atheroma Arterioscler Thromb Vasc Biol 21 7 1124 1130 11451740 10.1161/hq0701.092145 1:CAS:528:DC%2BD3MXltlKmsr8%3D (Pubitemid 34215139)
66. K Honey AY Rudensky 2003 Lysosomal cysteine proteases regulate antigen presentation Nat Rev Immunol 3 6 472 482 12776207 10.1038/nri1110 1:CAS:528:DC%2BD3sXktFOhtbo%3D (Pubitemid 37339187)
67. LC Hsing AY Rudensky 2005 The lysosomal cysteine proteases in MHC class II antigen presentation Immunol Rev 207 229 241 16181340 10.1111/j.0105-2896. 2005.00310.x 1:CAS:528:DC%2BD2MXhtFOqtL%2FJ (Pubitemid 41415021)
68. GP Shi RA Bryant R Riese S Verhelst C Driessen Z Li, et al. 2000 Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages J Exp Med 191 7 1177 1186 10748235 10.1084/jem.191.7.1177 1:CAS:528:DC%2BD3cXit1ygurg%3D (Pubitemid 30207680)
69. T Nakagawa W Roth P Wong A Nelson A Farr J Deussing, et al. 1998 Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus Science 280 5362 450 453 9545226 10.1126/science.280.5362.450 1:CAS:528:DyaK1cXivVeku7c%3D (Pubitemid 28208170)
70. GP Shi JA Villadangos G Dranoff C Small L Gu KJ Haley, et al. 1999 Cathepsin S required for normal MHC class II peptide loading and germinal center development Immunity 10 2 197 206 10072072 10.1016/S1074-7613(00)80020-5 1:CAS:528:DyaK1MXhs1ymsro%3D (Pubitemid 29115625)
71. E Tolosa W Li Y Yasuda W Wienhold LK Denzin A Lautwein, et al. 2003 Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis J Clin Invest 112 4 517 526 12925692 1:CAS:528:DC%2BD3sXms1Wntbk%3D (Pubitemid 38056336)
72. I Podgorski 2009 Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis? Future Med Chem 1 1 21 34 20126511 10.4155/fmc.09.4 1:CAS:528:DC%2BD1MXhtFSgur7K
73. J Sun K Hartvigsen MY Chou Y Zhang GK Sukhova J Zhang, et al. 2010 Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice Circulation 122 8 808 820 20697023 10.1161/CIRCULATIONAHA.109.891887 1:CAS:528:DC%2BC3cXhtVKju7%2FO
74. AT Hirsch ZJ Haskal NR Hertzer CW Bakal MA Creager JL Halperin, et al. 2006 ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 11 e463 e654 16549646 10.1161/CIRCULATIONAHA.106.174526
75. T Reinheckel J Deussing W Roth C Peters 2001 Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L Biol Chem 382 5 735 741 11517926 10.1515/BC.2001.089 1:CAS:528:DC%2BD3MXlvFSksb4%3D (Pubitemid 32631710)
76. C Palermo JA Joyce 2008 Cysteine cathepsin proteases as pharmacological targets in cancer Trends Pharmacol Sci 29 1 22 28 18037508 10.1016/j.tips.2007. 10.011 1:CAS:528:DC%2BD1cXis1eiug%3D%3D
77. U Grabowskal TJ Chambers M Shiroo 2005 Recent developments in cathepsin K inhibitor design Curr Opin Drug Discov Devel 8 5 619 630 16159024 (Pubitemid 41224125)
78. JY Gauthier WC Black I Courchesne W Cromlish S Desmarais R Houle, et al. 2007 The identification of potent, selective, and bioavailable cathepsin S inhibitors Bioorg Med Chem Lett 17 17 4929 4933 17590332 10.1016/j.bmcl.2007.06. 023 1:CAS:528:DC%2BD2sXos1antLs%3D (Pubitemid 47187680)
79. E Aikawa M Aikawa P Libby JL Figueiredo G Rusanescu Y Iwamoto, et al. 2009 Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease Circulation 119 13 1785 1794 19307473 10.1161/CIRCULATIONAHA.108.827972 1:CAS:528:DC%2BD1MXjslKksr8%3D
80. WC Black MD Percival 2006 The consequences of lysosomotropism on the design of selective cathepsin K inhibitors Chembiochem 7 10 1525 1535 16921579 10.1002/cbic.200600149 1:CAS:528:DC%2BD28XhtFemsrrO (Pubitemid 44555997)
81. EM Lewiecki 2009 Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling IDrugs 12 12 799 809 19943223 1:CAS:528:DC%2BC3cXpt1yrtLg%3D
82. TD Rachner S Khosla LC Hofbauer 2011 Osteoporosis: now and the future Lancet 377 9773 1276 1287 21450337 10.1016/S0140-6736(10)62349-5 1:CAS:528:DC%2BC3MXksFWit7c%3D